Explores payer perspectives on using patient experience data for formulary decisions, suggesting significant insights.
As defined by the 21st Century Cures Act, patient experience data (PED) are data collected by any person with the purpose of providing information about patients’ experiences with a disease or condition. To date, limited information is available on payer perspectives and the use of PED in formulary decision-making beyond patient-reported outcomes.
No takes yet. Share an insight, caveat, or question.
Kheloussi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: